Company Filing History:
Years Active: 2016-2018
Title: Gregory Blinder: Innovator in Human Milk Fat Substitutes
Introduction
Gregory Blinder is a notable inventor based in Kiryat Motzkin, Israel. He has made significant contributions to the field of food science, particularly in the development of human milk fat substitutes. With a total of 2 patents, his work has the potential to impact infant nutrition positively.
Latest Patents
Blinder's latest patents focus on the preparation of human milk fat substitutes. These patents disclose processes for creating human milk fat (HMF) substitutes, which include a fat base composition made from vegetable-derived triglycerides. The composition is designed to have less than 50% of the fatty acid residues bonded at the sn-2 position being saturated. Additionally, the amount of saturated fatty acid residues at this position is kept below approximately 43.5% of the total fatty acid residues. The invention typically utilizes palmitic acid residues for the saturated fatty acids at the sn-2 position. The patents also cover infant formulas that incorporate these innovative fat base compositions.
Career Highlights
Gregory Blinder is associated with Enzymotec Ltd., a company that specializes in developing innovative nutritional products. His work at Enzymotec has allowed him to explore and implement his ideas in a practical setting, contributing to advancements in infant nutrition.
Collaborations
Blinder has collaborated with notable colleagues such as Avidor Shulman and Gai Ben Dror. These collaborations have likely enhanced the research and development efforts in the field of human milk fat substitutes.
Conclusion
Gregory Blinder's contributions to the development of human milk fat substitutes represent a significant advancement in infant nutrition. His innovative patents and work at Enzymotec Ltd. highlight his commitment to improving dietary options for infants.